Literature DB >> 8803914

The use of hydroxychloroquine in lupus pregnancy: the British experience.

M A Khamashta1, N M Buchanan, G R Hughes.   

Abstract

Hydroxychloroquine (HCQ) is a valuable and possibly underused agent in treating mild lupus. Whether this drug should be discontinued in pregnancy is still controversial. We studied the full obstetric histories of 33 women with lupus who had taken HCQ at some point during pregnancy. HCQ was not, apparently, teratogenic and we believe that continuation of this drug is probably safe in lupus pregnancies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803914

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Management of antiphospholipid syndrome.

Authors:  Nicoletta Del Papa; Nikoleta Vaso
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-08       Impact factor: 5.346

2.  Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?

Authors:  Jinoos Yazdany; Laura Trupin; Rachel Kaiser; Gabriela Schmajuk; Joann Zell Gillis; Eliza Chakravarty; Eleanor Bimla Schwarz
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-11-15       Impact factor: 4.794

3.  Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases.

Authors:  Kirk Sperber; Christine Hom; Chun Peng Chao; Deborah Shapiro; Julia Ash
Journal:  Pediatr Rheumatol Online J       Date:  2009-05-13       Impact factor: 3.054

Review 4.  New concepts in antimalarial use and mode of action in dermatology.

Authors:  Sunil Kalia; Jan P Dutz
Journal:  Dermatol Ther       Date:  2007 Jul-Aug       Impact factor: 2.851

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.